Log in
Enquire now
‌

US Patent 12005081 Chimeric receptors and methods of use thereof

Patent 12005081 was granted and assigned to Senti Biosciences on June, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Senti Biosciences
Senti Biosciences
0
Date Filed
June 3, 2021
0
Date of Patent
June 11, 2024
0
Patent Applicant
Senti Biosciences
Senti Biosciences
0
Patent Application Number
17338528
0
Patent Citations
‌
US Patent 7446190 Nucleic acids encoding chimeric T cell receptors
0
‌
US Patent 7022500 Humanized immunoglobulins
0
‌
US Patent 7183385 Phospho-specific antibodies to Flt3 and uses thereof
0
‌
US Patent 7304149 BTLA nucleic acids
0
‌
US Patent 10172885 Cell
0
‌
US Patent 10172886 Cell
0
‌
US Patent 10426797 Compositions and methods for treating cancer with anti-CD33 immunotherapy
0
‌
US Patent 10428305 Modified natural killer cells that express IL15 and uses thereof
0
‌
US Patent 10577417 Targeting cytotoxic cells with chimeric receptors for adoptive immunotherapy
0
‌
US Patent 10829556 Polynucleotides encoding bispecific chimeric antigen receptors
0
•••
Patent Inventor Names
Jennifer Chien
0
Kathryn Armstrong Loving
0
Russell Morrison Gordley
0
Brian Scott Garrison
0
Michelle Elizabeth Hung
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
12005081
0
Patent Primary Examiner
‌
Maria Marvich
0

Find more entities like US Patent 12005081 Chimeric receptors and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.